|
Markt geschlossen -
Börse Stuttgart
21:55:42 18.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 11.48 EUR | -1.54% |
|
-11.15% | +125.10% |
| 15.09. | Französische und Benelux-Aktien - Faktoren im Blick am 15. September | RE |
| 15.09. | Frankreichs Genfit plant Phase-2a-Studie zu Behandlung von Leberversagen | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.11% | +2.71% | -5.80% | +9.40% | +1.45% | +0.44% | +26.85% | -27.52% | +198.14% | 46.28 Mrd. | ||
| -1.12% | +1.78% | +6.88% | +58.80% | +18.19% | +42.30% | +27.55% | +3.94% | +244.30% | 43.85 Mrd. | ||
| -3.04% | -6.29% | -11.05% | +17.15% | +139.74% | +338.56% | +515.97% | +511.43% | - | 40.93 Mrd. | ||
| -0.74% | +1.25% | -6.90% | +29.87% | +15.48% | +4.92% | +67.98% | -12.97% | +1’035.77% | 39.89 Mrd. | ||
| -0.50% | +0.67% | -7.57% | +5.34% | +4.07% | +10.29% | +41.28% | -20.80% | +138.37% | 29.5 Mrd. | ||
| -0.46% | +4.22% | +0.67% | +33.06% | +9.02% | +22.81% | +139.44% | +229.17% | +1’903.04% | 17.09 Mrd. | ||
| -0.97% | -10.17% | -8.82% | +2.55% | - | - | - | - | - | 15.55 Mrd. | ||
| -0.57% | +8.12% | +8.18% | +22.26% | +22.50% | +22.19% | +38.68% | -39.09% | +95.97% | 15.22 Mrd. | ||
| -3.14% | +31.91% | +27.09% | +53.11% | +31.82% | -11.79% | - | - | - | 14.05 Mrd. | ||
| -1.28% | -0.07% | -4.12% | +50.30% | +39.39% | +78.94% | +33.34% | -36.87% | +245.54% | 13.27 Mrd. | ||
| -3.28% | -3.07% | -4.86% | +12.40% | -9.94% | -5.68% | -37.66% | -38.81% | +118.20% | 12.66 Mrd. | ||
| +5.70% | +21.57% | +33.99% | +233.67% | +216.75% | +130.60% | +94.27% | +16.74% | +1’461.11% | 11.43 Mrd. | ||
| -0.06% | +0.35% | -0.15% | +24.91% | +23.06% | +36.16% | +2.46% | -45.83% | +164.75% | 11.35 Mrd. | ||
| -1.03% | +7.50% | -10.63% | +90.66% | +52.30% | +23.68% | +52.63% | -55.92% | - | 10.89 Mrd. | ||
| -0.62% | +2.43% | -7.51% | +30.21% | +51.33% | +139.67% | +528.00% | +87.05% | - | 9.79 Mrd. | ||
| -0.49% | -3.50% | -7.71% | +26.71% | +63.73% | +129.90% | +708.82% | +715.74% | +847.02% | 9.25 Mrd. | ||
| -2.88% | -10.17% | -11.91% | +7.00% | -24.42% | +29.63% | +458.28% | +187.97% | +911.11% | 9.1 Mrd. | ||
| -2.37% | +1.95% | -2.63% | +17.27% | -8.46% | -10.40% | -3.22% | -28.56% | +42.90% | 8.96 Mrd. | ||
| -3.71% | -10.65% | -22.59% | +5.89% | +1.43% | +608.08% | +1’246.62% | -0.15% | - | 8.35 Mrd. | ||
| Durchschnitt | -1.08% | +1.97% | -1.87% | +38.45% | +35.97% | +88.35% | +231.84% | +85.03% | +569.71% | 19.34 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -1.04% | +1.61% | -2.31% | +33.56% | +36.32% | +78.87% | +172.84% | +85.94% | +519.34% |
- Börse
- Aktien
- A0LGJ2 Aktie
- A0LGJ2 Aktie
- Sektor GENFIT
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















